[go: up one dir, main page]

NO20055467L - Fremgangsmate til fremstilling av molekylaere komplekser - Google Patents

Fremgangsmate til fremstilling av molekylaere komplekser

Info

Publication number
NO20055467L
NO20055467L NO20055467A NO20055467A NO20055467L NO 20055467 L NO20055467 L NO 20055467L NO 20055467 A NO20055467 A NO 20055467A NO 20055467 A NO20055467 A NO 20055467A NO 20055467 L NO20055467 L NO 20055467L
Authority
NO
Norway
Prior art keywords
molecular complexes
preparation
molecular
recovered
consist
Prior art date
Application number
NO20055467A
Other languages
English (en)
Other versions
NO335160B1 (no
Inventor
Hubert Lochard
Martial Sauceau
Bernard Freiss
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of NO20055467L publication Critical patent/NO20055467L/no
Publication of NO335160B1 publication Critical patent/NO335160B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

Oppfirmelsen angår en fremgangsmåte til fremstilhng av oppløselige molekylære komplekser som omfatter ett eller flere aktive stoffer som er lite oppløselige i et vandig medium, inkludert i ett eller flere vertsmolekyler, kjermetegnet ved at det omfatter følgende trirm: (a) å bringe ett eller flere aktive stoffer i kontakt med ett eller flere vertsmolekyler, (b) å utføre et molekylært diffusjonstrirm ved å bringe en tett fluid i kontakt, under trykk, med blandingen oppnådd i (a), i statisk modus, i nærvær av ett eller flere diffiisjonsmidler og (c) gjenvirming av det molekylære kompleks således dannet.
NO20055467A 2003-04-25 2005-11-18 Fremgangsmåte til fremstilling av molekylære komplekser NO335160B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0305140A FR2854079B1 (fr) 2003-04-25 2003-04-25 Procede de preparation de complexes moleculaires
PCT/FR2004/000995 WO2004096284A1 (fr) 2003-04-25 2004-04-23 Procede de preparation de complexes moleculaires

Publications (2)

Publication Number Publication Date
NO20055467L true NO20055467L (no) 2005-11-18
NO335160B1 NO335160B1 (no) 2014-10-06

Family

ID=33104420

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055467A NO335160B1 (no) 2003-04-25 2005-11-18 Fremgangsmåte til fremstilling av molekylære komplekser

Country Status (22)

Country Link
US (1) US8741346B2 (no)
EP (2) EP2289561A1 (no)
JP (1) JP5037936B2 (no)
KR (1) KR101208256B1 (no)
CN (1) CN100594941C (no)
AT (1) ATE555811T1 (no)
AU (1) AU2004233621B2 (no)
BR (1) BRPI0409741B1 (no)
CA (1) CA2523342C (no)
DK (1) DK1638609T3 (no)
ES (1) ES2386437T3 (no)
FR (1) FR2854079B1 (no)
IL (1) IL171520A (no)
MX (1) MXPA05011505A (no)
NO (1) NO335160B1 (no)
NZ (1) NZ543209A (no)
PL (1) PL1638609T3 (no)
PT (1) PT1638609E (no)
RU (2) RU2353392C2 (no)
SI (1) SI1638609T1 (no)
WO (1) WO2004096284A1 (no)
ZA (1) ZA200508469B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
JP5091661B2 (ja) * 2004-04-01 2012-12-05 ピエール ファーブル メディカモン 超臨界ｃｏ２と錯体相互作用剤を用いる方法によって得られる包接錯体
FR2876914A1 (fr) * 2004-10-21 2006-04-28 Pierre Fabre Medicament Sa Complexe comprenant un antibiotique, une cyclodextrine et un agent d'interaction
FR2876910B1 (fr) 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
FR2944280B1 (fr) * 2009-04-09 2012-08-03 Galderma Res & Dev Procede de preparation de complexes moleculaires entre adapalene et des cyclodextrines
FR2944278B1 (fr) * 2009-04-09 2011-11-18 Pf Medicament Procede de preparation de complexes moleculaires entre un agent retinoide et des cyclodextrines
FR2944207B1 (fr) * 2009-04-09 2011-05-06 Galderma Res & Dev Compositions comprenant au moins un complexe compose d'un derive d'acide naphtoique et d'au moins une cyclodestrine et leurs utilisations
JP5622187B2 (ja) * 2009-09-08 2014-11-12 群泰生物科技股▲ふん▼有限公司 水溶性ミノキシジル組成物
US10328152B2 (en) 2011-06-16 2019-06-25 Nayan Patel Method for stabilization and delivery of therapeutic molecules
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
AU2020370166B2 (en) * 2019-10-21 2022-05-19 Esolate Ltd Superfine compounds and production thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2191715B (en) 1986-06-17 1990-07-25 Midrex Int Bv Method and apparatus for dedusting and desulfurizing gases
JPH0677511B2 (ja) 1986-12-05 1994-10-05 金印わさび株式会社 香辛成分の包接化合物の製造方法
US4822497A (en) 1987-09-22 1989-04-18 Modar, Inc. Method for solids separation in a wet oxidation type process
DE3744329A1 (de) 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
FR2629735B1 (fr) 1988-04-11 1991-03-22 Agronomique Inst Nat Rech Procede d'extraction au dioxyde de carbone supercritique de composes volatils, et composes obtenus
RU2108109C1 (ru) * 1990-10-04 1998-04-10 Мадаус АГ Способ получения комплекса силибинина с циклодекстрином, комплекс включения силибинина с циклодекстрином, фармацевтическая композиция антигепатотоксической активности и способ ее получения
GB9100643D0 (en) 1991-01-11 1991-02-27 Shaffery Michael J Filter system
JP3043085B2 (ja) 1991-03-18 2000-05-22 日本たばこ産業株式会社 包接化合物の製造方法
US5389263A (en) 1992-05-20 1995-02-14 Phasex Corporation Gas anti-solvent recrystallization and application for the separation and subsequent processing of RDX and HMX
JPH09502698A (ja) * 1993-03-05 1997-03-18 ヘクサル・アクチエンゲゼルシャフト 塩酸ラニチジンの結晶シクロデキストリン複合体、その製造方法およびその複合体を含有する薬剤組成物
EP0616801B1 (de) 1993-03-24 1998-05-27 Novartis AG Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
GB9313642D0 (en) 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
EP0706821A1 (en) 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
FR2725990B1 (fr) 1994-10-21 1997-01-10 Pf Medicament Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux
FR2741619B1 (fr) 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
JP3986086B2 (ja) 1996-03-01 2007-10-03 ザ ユニバーシティ オブ カンザス 近臨界および超臨界反溶媒を用いる粒子析出方法および被覆方法
FR2753639B1 (fr) 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
DE19711393C1 (de) 1997-03-19 1998-08-13 Fraunhofer Ges Forschung Verfahren zum Mikroverkapseln von Partikeln
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
IT1296464B1 (it) 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9810559D0 (en) 1998-05-15 1998-07-15 Bradford Particle Design Ltd Method and apparatus for particle formation
GB9824298D0 (en) 1998-11-05 1998-12-30 Smithkline Beecham Plc Novel process
FR2798863B1 (fr) 1999-09-27 2001-12-28 Separex Sa Procede et installation de mise a l'etat adsorbe sur un support poreux de composes actifs contenus dans un produit
FR2799984B1 (fr) 1999-10-21 2002-05-03 Lavipharm Procede de fractionnement d'une matiere composee de plusieurs constituants a l'aide d'un solvant a pression supercritique
FR2803538B1 (fr) 1999-12-15 2002-06-07 Separex Sa Procede et dispositif de captage de fines particules par percolation dans un lit de granules
FR2815540B1 (fr) * 2000-10-19 2005-06-10 Separex Sa Procede de fabrication de tres fines particules constituees d'un principe insere dans une molecule hote
WO2002089851A1 (fr) 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client
FR2823207B1 (fr) * 2001-04-10 2004-12-03 Pf Medicament Complexes d'anilides a chaine polycarbonee et de cyclodestrines, leur preparation et leur application en tant que medicamment en particulier pour le traitement des dislipidemies
FR2830761B1 (fr) * 2001-10-12 2003-12-12 Pf Medicament Procede de preparation d'un compose d'interaction d'un derive anilide avec un support poreux par fluide supercritique
FR2830760B1 (fr) * 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique

Also Published As

Publication number Publication date
DK1638609T3 (da) 2012-08-20
HK1082430A1 (en) 2006-06-09
ATE555811T1 (de) 2012-05-15
KR20060011974A (ko) 2006-02-06
CN100594941C (zh) 2010-03-24
FR2854079A1 (fr) 2004-10-29
US8741346B2 (en) 2014-06-03
FR2854079B1 (fr) 2007-11-30
RU2008137041A (ru) 2010-03-20
EP1638609A1 (fr) 2006-03-29
PL1638609T3 (pl) 2012-09-28
WO2004096284A1 (fr) 2004-11-11
AU2004233621B2 (en) 2009-11-19
CA2523342A1 (fr) 2004-11-11
ZA200508469B (en) 2006-07-26
AU2004233621A1 (en) 2004-11-11
ES2386437T3 (es) 2012-08-21
IL171520A (en) 2011-07-31
CA2523342C (fr) 2012-12-04
KR101208256B1 (ko) 2012-12-05
JP2006524670A (ja) 2006-11-02
EP1638609B1 (fr) 2012-05-02
MXPA05011505A (es) 2005-12-15
PT1638609E (pt) 2012-07-24
JP5037936B2 (ja) 2012-10-03
CN1795014A (zh) 2006-06-28
RU2005136664A (ru) 2006-03-10
NO335160B1 (no) 2014-10-06
EP2289561A1 (fr) 2011-03-02
US20060246140A1 (en) 2006-11-02
SI1638609T1 (sl) 2012-09-28
RU2353392C2 (ru) 2009-04-27
BRPI0409741B1 (pt) 2016-12-06
BRPI0409741A (pt) 2006-05-09
NZ543209A (en) 2008-03-28

Similar Documents

Publication Publication Date Title
NO20055467L (no) Fremgangsmate til fremstilling av molekylaere komplekser
NO20055607L (no) Antilosemiddel solidifiseringsprosess
WO2006117517A3 (en) Acidic treatment fluids comprising scleroglucan and/or diutan and associated methods
DK1590006T3 (da) Ultralydskontrastmidler og fremgangsmåde til frembringelse deraf
DE60320654D1 (de) Verfahren zur behandlung einer formation
CA2517063A1 (en) A method of using a swelling agent to prevent a cement slurry from being lost to a subterranean formation
ATE295185T1 (de) Verfahren zur herstellung von sehr feinen teilchen bestehend aus einem wirtsmolekül mit inseriertem wirkstoff
DE602005024919D1 (de) Biokompatibles vernetztes gel
NZ520671A (en) Foaming agents for use in coal seam reservoirs
SE0202114L (sv) Polymeraffinitetsmatris, förfarande för framställning därav och anvädning därav
ATE432063T1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
DE60017457D1 (de) Verfahren zur isolierung eines fehlers in fehlernachrichten
DE60143261D1 (de) Hämatologie-blutkontrolle und verfahren zu ihrer herstellung
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
DE60231301D1 (de) Teilchen vom kern-schale-typ mit einer darin enthaltenen signalerzeugenden substanz und verfahren zur herstellung davon
NO20055641L (no) Fremgangsmate for a behandle en underjordisk formasjon og vannbasert behandlingsvaeske til bruk ved utforelsen av fremgangsmaten
AR070347A1 (es) Uso de modificadores de permeabilidad relativa en el tratamiento de formaciones subterraneas
MX2009008895A (es) Reticulacion de galactomanano libre de metal.
BR0213220A (pt) Processo de preparação de compostos de interação de uma substância ativa pouco solúvel em um meio aquoso com um suporte poroso, e, composto de interação de interação de uma substância ativa pouco solúvel em um meio aquoso em um suporte aquoso
AR032016A1 (es) Una composicion catalizadora y los metodos para su preparacion y el uso en un proceso de polimerizacion
ATE546130T1 (de) Dispersion von polymerteilchen
RU2464415C2 (ru) Способ заводнения нефтяного пласта
WO2005097201A3 (fr) Complexes d’inclusions comprenant du piroxicam, une cyclodextrine et l’arginine
RU94008060A (ru) Способ вытеснения нефти из неоднородных по проницаемости карбонатных пластов
DE60226767D1 (de) Materialien und methoden zum reduzieren der konzentration von oxalat in fluiden

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees